| NCT03823950 |
Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients |
https://ClinicalTrials.gov/show/NCT03823950 |
Recruiting |
University of Mississippi Medical Center |
2021-12-31 |
| NCT03333486 |
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer |
https://ClinicalTrials.gov/show/NCT03333486 |
Recruiting |
Roswell Park Cancer Institute |
2022-09-06 |
| NCT03333005 |
Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and Neutropenia |
https://ClinicalTrials.gov/show/NCT03333005 |
Completed |
Amplyx Pharmaceuticals |
2018-10-26 |
| NCT03314805 |
PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy |
https://ClinicalTrials.gov/show/NCT03314805 |
Recruiting |
PhytoHealth Corporation |
2020-12-31 |
| NCT03294577 |
Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia |
https://ClinicalTrials.gov/show/NCT03294577 |
Recruiting |
BeyondSpring Pharmaceuticals Inc. |
2020-06-15 |
| NCT03252431 |
Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy |
https://ClinicalTrials.gov/show/NCT03252431 |
Active, not recruiting |
Generon (Shanghai) Corporation Ltd. |
2019-09-25 |
| NCT03251768 |
Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients |
https://ClinicalTrials.gov/show/NCT03251768 |
Completed |
Tianjin SinoBiotech Ltd. |
2018-07-23 |
| NCT03246009 |
Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients |
https://ClinicalTrials.gov/show/NCT03246009 |
Completed |
Tianjin SinoBiotech Ltd. |
2017-04-10 |
| NCT03233776 |
Anakinra: Safety and Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT |
https://ClinicalTrials.gov/show/NCT03233776 |
Active, not recruiting |
Radboud University |
2019-05-07 |
| NCT03208816 |
Community-Led Action Research in Oncology: Improving Symptom Management |
https://ClinicalTrials.gov/show/NCT03208816 |
Completed |
Dartmouth-Hitchcock Medical Center |
2017-12-31 |
| NCT03182465 |
Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department for Low Risk Chemo-induced Febrile Neutropenia |
https://ClinicalTrials.gov/show/NCT03182465 |
Recruiting |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2020-08-25 |
| NCT03104595 |
Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer |
https://ClinicalTrials.gov/show/NCT03104595 |
Recruiting |
Enzychem Lifesciences Corporation |
2018-12-31 |
| NCT03102606 |
Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 |
https://ClinicalTrials.gov/show/NCT03102606 |
Recruiting |
BeyondSpring Pharmaceuticals Inc. |
2020-06-01 |
| NCT03087227 |
Shared Health Information System for Febrile Neutropenia |
https://ClinicalTrials.gov/show/NCT03087227 |
Recruiting |
University of Paris 13 |
2019-11-30 |
| NCT03078010 |
Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT03078010 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-02-28 |
| NCT03019939 |
Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia |
https://ClinicalTrials.gov/show/NCT03019939 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-03-01 |
| NCT02953340 |
SPI-2012 vs Pegfilgrastim in Management of Neutropenia in BReast Cancer Patients With Docetaxel and Cyclophosphamide |
https://ClinicalTrials.gov/show/NCT02953340 |
Completed |
Spectrum Pharmaceuticals, Inc |
2017-08-27 |
| NCT02872103 |
Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy |
https://ClinicalTrials.gov/show/NCT02872103 |
Completed |
Generon (Shanghai) Corporation Ltd. |
2017-12-20 |
| NCT02816112 |
Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia |
https://ClinicalTrials.gov/show/NCT02816112 |
Completed |
Ottawa Hospital Research Institute |
2020-03-31 |
| NCT02805205 |
PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia |
https://ClinicalTrials.gov/show/NCT02805205 |
Completed |
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. |
2016-02-29 |
| NCT02778763 |
Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis |
https://ClinicalTrials.gov/show/NCT02778763 |
Completed |
BioLab 612 LLC |
2016-07-31 |
| NCT02755857 |
Bioavailability Study of Lozanocâ„¢ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis |
https://ClinicalTrials.gov/show/NCT02755857 |
Completed |
Mayne Pharma International Pty Ltd |
2016-12-31 |
| NCT02728596 |
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) |
https://ClinicalTrials.gov/show/NCT02728596 |
Recruiting |
Southwest Oncology Group |
2021-04-30 |
| NCT02700360 |
Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT02700360 |
Completed |
Enzychem Lifesciences Corporation |
2015-10-31 |
| NCT02692742 |
Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia |
https://ClinicalTrials.gov/show/NCT02692742 |
Completed |
Myelo Therapeutics GmbH |
2017-11-30 |
| NCT02679443 |
Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy |
https://ClinicalTrials.gov/show/NCT02679443 |
Completed |
Postgraduate Institute of Medical Education and Research |
2016-12-31 |
| NCT02643901 |
Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT02643901 |
Completed |
Jiangsu T-Mab Biopharma Co.,Ltd |
2016-10-10 |
| NCT02643420 |
SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Breast CANCEr Patients With Docetaxel and Cyclophosphamide |
https://ClinicalTrials.gov/show/NCT02643420 |
Completed |
Spectrum Pharmaceuticals, Inc |
2017-08-18 |
| NCT02629289 |
A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants |
https://ClinicalTrials.gov/show/NCT02629289 |
Completed |
Pfizer |
2016-06-30 |
| NCT02621905 |
Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg |
https://ClinicalTrials.gov/show/NCT02621905 |
Completed |
Mayne Pharma International Pty Ltd |
2016-11-30 |
| NCT02589301 |
Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations |
https://ClinicalTrials.gov/show/NCT02589301 |
Completed |
Eurofarma Laboratorios S.A. |
2016-03-31 |
| NCT02231879 |
Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome |
https://ClinicalTrials.gov/show/NCT02231879 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2020-10-05 |
| NCT00967785 |
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS |
https://ClinicalTrials.gov/show/NCT00967785 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-12-31 |
| NCT02544685 |
Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients |
https://ClinicalTrials.gov/show/NCT02544685 |
Active, not recruiting |
S&D Pharma SK s.r.o. |
2019-09-30 |
| NCT02532712 |
Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT02532712 |
Completed |
Enzychem Lifesciences Corporation |
2015-12-31 |
| NCT02527746 |
Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy |
https://ClinicalTrials.gov/show/NCT02527746 |
Completed |
Generon (Shanghai) Corporation Ltd. |
2013-12-31 |
| NCT02522234 |
A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy |
https://ClinicalTrials.gov/show/NCT02522234 |
Completed |
Generon (Shanghai) Corporation Ltd. |
2015-08-19 |
| NCT02521441 |
A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy. |
https://ClinicalTrials.gov/show/NCT02521441 |
Completed |
Generon (Shanghai) Corporation Ltd. |
2015-09-20 |
| NCT02496143 |
A Safety and PK Study of EC-18 in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT02496143 |
Completed |
Enzychem Lifesciences Corporation |
2015-12-31 |
| NCT02467868 |
Efficacy and Safety Study With MYL-1401H and Neulasta |
https://ClinicalTrials.gov/show/NCT02467868 |
Completed |
Mylan Inc. |
2015-09-30 |
| NCT02465801 |
Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein |
https://ClinicalTrials.gov/show/NCT02465801 |
Completed |
Tianjin SinoBiotech Ltd. |
2015-12-23 |
| NCT02452034 |
Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097) |
https://ClinicalTrials.gov/show/NCT02452034 |
Completed |
Merck Sharp & Dohme Corp. |
2018-06-26 |
| NCT02414581 |
Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7% |
https://ClinicalTrials.gov/show/NCT02414581 |
Completed |
Hospital Regional de Alta Especialidad del Bajio |
2016-08-31 |
| NCT02404155 |
Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN) |
https://ClinicalTrials.gov/show/NCT02404155 |
Active, not recruiting |
University of Maryland, Baltimore |
2020-04-30 |
| NCT02282215 |
Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02282215 |
Completed |
Cellerant Therapeutics |
2017-09-22 |
| NCT02251977 |
Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT02251977 |
Completed |
Sun Yat-sen University |
2017-09-05 |
| NCT02213783 |
Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia |
https://ClinicalTrials.gov/show/NCT02213783 |
Completed |
Prince of Songkla University |
2013-07-31 |
| NCT02190721 |
A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement |
https://ClinicalTrials.gov/show/NCT02190721 |
Completed |
Teva Pharmaceutical Industries |
2017-04-04 |
| NCT02179359 |
Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies |
https://ClinicalTrials.gov/show/NCT02179359 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2020-08-31 |
| NCT02156388 |
Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors |
https://ClinicalTrials.gov/show/NCT02156388 |
Completed |
Jiangsu T-Mab Biopharma Co.,Ltd |
2015-02-28 |
| NCT02149329 |
Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO |
https://ClinicalTrials.gov/show/NCT02149329 |
Completed |
VU University Medical Center |
2019-08-05 |
| NCT02119715 |
A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT02119715 |
Completed |
Jiangsu HengRui Medicine Co., Ltd. |
2012-08-31 |
| NCT02104830 |
Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients |
https://ClinicalTrials.gov/show/NCT02104830 |
Completed |
Biocad |
2014-06-30 |
| NCT01307579 |
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01307579 |
Active, not recruiting |
Children’s Oncology Group |
2018-06-30 |
| NCT02044276 |
A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia |
https://ClinicalTrials.gov/show/NCT02044276 |
Completed |
Teva Pharmaceutical Industries |
2017-08-29 |
| NCT02005783 |
Study of Danggui Buxue Decoction in Preventing Neutropenia |
https://ClinicalTrials.gov/show/NCT02005783 |
Completed |
Shanghai Jiao Tong University School of Medicine |
2015-08-31 |
| NCT02005458 |
Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT02005458 |
Completed |
Xiamen Amoytop Biotech Co., Ltd. |
2017-03-31 |
| NCT01974401 |
Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood Dyscrasia |
https://ClinicalTrials.gov/show/NCT01974401 |
Completed |
Mashhad University of Medical Sciences |
2011-03-31 |
| NCT01966367 |
CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT01966367 |
Active, not recruiting |
Columbia University |
2022-01-31 |
| NCT01923545 |
Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia |
https://ClinicalTrials.gov/show/NCT01923545 |
Completed |
Dong-A ST Co., Ltd. |
2011-05-31 |
| NCT01919710 |
Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia |
https://ClinicalTrials.gov/show/NCT01919710 |
Completed |
Tianjin SinoBiotech Ltd. |
2014-06-30 |
| NCT01917708 |
Bone Marrow Transplant With Abatacept for Non-Malignant Diseases |
https://ClinicalTrials.gov/show/NCT01917708 |
Completed |
Emory University |
2019-09-19 |
| NCT01916057 |
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis |
https://ClinicalTrials.gov/show/NCT01916057 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2017-06-01 |
| NCT01852370 |
Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases |
https://ClinicalTrials.gov/show/NCT01852370 |
Enrolling by invitation |
University of Pittsburgh |
2023-11-30 |
| NCT01735175 |
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta® |
https://ClinicalTrials.gov/show/NCT01735175 |
Completed |
Sandoz |
2013-05-31 |
| NCT01724866 |
Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients |
https://ClinicalTrials.gov/show/NCT01724866 |
Completed |
Spectrum Pharmaceuticals, Inc |
2014-12-31 |
| NCT01714570 |
Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia |
https://ClinicalTrials.gov/show/NCT01714570 |
Completed |
Chinese PLA General Hospital |
2014-03-31 |
| NCT01674855 |
Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia |
https://ClinicalTrials.gov/show/NCT01674855 |
Completed |
Dong-A ST Co., Ltd. |
2013-02-28 |
| NCT01649635 |
Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer |
https://ClinicalTrials.gov/show/NCT01649635 |
Completed |
Sanofi |
2014-01-31 |
| NCT01648322 |
Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy |
https://ClinicalTrials.gov/show/NCT01648322 |
Completed |
Generon (Shanghai) Corporation Ltd. |
2014-12-31 |
| NCT01629082 |
Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01629082 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-10-27 |
| NCT01611051 |
A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT01611051 |
Completed |
Jiangsu HengRui Medicine Co., Ltd. |
2013-01-31 |
| NCT01581333 |
Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia |
https://ClinicalTrials.gov/show/NCT01581333 |
Completed |
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla |
2016-05-31 |
| NCT01569087 |
Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer |
https://ClinicalTrials.gov/show/NCT01569087 |
Completed |
Biocad |
2013-01-31 |
| NCT01529827 |
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01529827 |
Completed |
Roswell Park Cancer Institute |
2015-05-28 |
| NCT01519700 |
Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim |
https://ClinicalTrials.gov/show/NCT01519700 |
Completed |
Sandoz |
2013-06-30 |
| NCT01516736 |
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim |
https://ClinicalTrials.gov/show/NCT01516736 |
Completed |
Sandoz |
2013-08-31 |
| NCT01484015 |
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia |
https://ClinicalTrials.gov/show/NCT01484015 |
Completed |
Wake Forest University Health Sciences |
2012-06-30 |
| NCT01401010 |
Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients |
https://ClinicalTrials.gov/show/NCT01401010 |
Completed |
Michigan State University |
2012-02-29 |
| NCT01375608 |
Decitabine for High-Risk Sickle Cell Disease |
https://ClinicalTrials.gov/show/NCT01375608 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-12-31 |
| NCT01371656 |
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT01371656 |
Completed |
Children’s Oncology Group |
2017-06-30 |
| NCT01344681 |
Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases |
https://ClinicalTrials.gov/show/NCT01344681 |
Completed |
Yonsei University |
2014-03-31 |
| NCT01328938 |
GCPGC in Chemotherapy-induced Neutropenia |
https://ClinicalTrials.gov/show/NCT01328938 |
Completed |
Green Cross Corporation |
2012-11-30 |
| NCT04345900 |
Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2 |
https://ClinicalTrials.gov/show/NCT04345900 |
Completed |
BeyondSpring Pharmaceuticals Inc. |
2018-03-20 |
| NCT04233996 |
Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients |
https://ClinicalTrials.gov/show/NCT04233996 |
Recruiting |
Hospital Universitari de Bellvitge |
2021-06-30 |
| NCT04227990 |
Plinabulin iv Solution in Prevention of TAC Induced Neutropenia |
https://ClinicalTrials.gov/show/NCT04227990 |
Completed |
BeyondSpring Pharmaceuticals Inc. |
2018-10-15 |
| NCT04187898 |
Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer |
https://ClinicalTrials.gov/show/NCT04187898 |
Recruiting |
Spectrum Pharmaceuticals, Inc |
2020-10-30 |
| NCT04187755 |
Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever |
https://ClinicalTrials.gov/show/NCT04187755 |
Completed |
Indonesia University |
2019-07-31 |
| NCT04171986 |
Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis |
https://ClinicalTrials.gov/show/NCT04171986 |
Recruiting |
Tianjin Medical University Cancer Institute and Hospital |
2021-10-31 |
| NCT04138251 |
Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency |
https://ClinicalTrials.gov/show/NCT04138251 |
Recruiting |
Cliniques universitaires Saint-Luc- Université Catholique de Louvain |
2020-06-30 |
| NCT04101760 |
Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT04101760 |
Recruiting |
Peking Union Medical College Hospital |
2020-10-01 |
| NCT04099901 |
Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT04099901 |
Recruiting |
Radboud University |
2021-10-31 |
| NCT04083079 |
Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in Lymphoma |
https://ClinicalTrials.gov/show/NCT04083079 |
Recruiting |
Ruijin Hospital |
2021-08-01 |
| NCT04081753 |
Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After Chemotherapy |
https://ClinicalTrials.gov/show/NCT04081753 |
Recruiting |
Augusta University |
2020-04-30 |
| NCT00837265 |
Neugranin in Breast Cancer Patients Receiving Doxorubicin/Docetaxel |
https://ClinicalTrials.gov/show/NCT00837265 |
Completed |
Teva Pharmaceutical Industries |
2009-09-30 |
| NCT03768869 |
Fever and Neutropenia in Pediatric Oncology Patients |
https://ClinicalTrials.gov/show/NCT03768869 |
Active, not recruiting |
University of Colorado, Denver |
2009-04-03 |
| NCT03740464 |
Long-acting G-CSF for Febrile Neutropenia |
https://ClinicalTrials.gov/show/NCT03740464 |
Recruiting |
Peking Union Medical College Hospital |
2019-11-10 |
| NCT03674294 |
Aprepitant Triple Therapy Caused Chemotherapy Induced Nausea And Vomiting In Gastrointestinal Tumors |
https://ClinicalTrials.gov/show/NCT03674294 |
Recruiting |
Sun Yat-sen University |
2019-12-29 |
| NCT03619252 |
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents |
https://ClinicalTrials.gov/show/NCT03619252 |
Enrolling by invitation |
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology |
2020-05-31 |
| NCT03513328 |
Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation |
https://ClinicalTrials.gov/show/NCT03513328 |
Recruiting |
University of Florida |
2021-06-30 |
| NCT03427593 |
Severe PID With Lymphoproliferation and Neutropenia |
https://ClinicalTrials.gov/show/NCT03427593 |
Completed |
University Hospital, Strasbourg, France |
2018-03-13 |
| NCT01229761 |
Study to Improve Survival Among HIV-Exposed Infants in Botswana |
https://ClinicalTrials.gov/show/NCT01229761 |
Completed |
Harvard School of Public Health |
2015-03-31 |
| NCT01200355 |
Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT01200355 |
Completed |
Memorial Sloan Kettering Cancer Center |
2017-04-20 |
| NCT01193283 |
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT01193283 |
Completed |
National Institutes of Health Clinical Center (CC) |
2014-09-30 |
| NCT01187017 |
A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT01187017 |
Completed |
National Institutes of Health Clinical Center (CC) |
2012-07-31 |
| NCT01164215 |
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy |
https://ClinicalTrials.gov/show/NCT01164215 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2012-11-30 |
| NCT01126190 |
Neugranin in Breast Cancer Patients Receiving Doxorubicin/Docetaxel (NEUGR-003) |
https://ClinicalTrials.gov/show/NCT01126190 |
Completed |
Teva Pharmaceutical Industries |
2012-02-29 |
| NCT01107756 |
A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen |
https://ClinicalTrials.gov/show/NCT01107756 |
Completed |
Sanofi |
2012-07-31 |
| NCT01086878 |
Safety of Cotrimoxazole in HIV- and HAART-exposed Infants |
https://ClinicalTrials.gov/show/NCT01086878 |
Completed |
Harvard School of Public Health |
2010-10-31 |
| NCT00928291 |
Procalcitonin Protocol to Shorten the Antibiotic Therapy in Febrile Neutropenia |
https://ClinicalTrials.gov/show/NCT00928291 |
Completed |
Federal University of Minas Gerais |
2011-04-30 |
| NCT00911170 |
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study |
https://ClinicalTrials.gov/show/NCT00911170 |
Completed |
Amgen |
2012-09-17 |
| NCT03793205 |
G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients |
https://ClinicalTrials.gov/show/NCT03793205 |
Recruiting |
Peking Union Medical College Hospital |
2020-01-01 |
| NCT00855309 |
Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia |
https://ClinicalTrials.gov/show/NCT00855309 |
Completed |
Wake Forest University Health Sciences |
2013-11-30 |
| NCT01114165 |
Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients |
https://ClinicalTrials.gov/show/NCT01114165 |
Completed |
University Hospital Muenster |
2012-09-30 |
| NCT01079676 |
A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer |
https://ClinicalTrials.gov/show/NCT01079676 |
Completed |
Eurofarma Laboratorios S.A. |
2011-04-30 |
| NCT02766647 |
A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen) |
https://ClinicalTrials.gov/show/NCT02766647 |
Completed |
Pfizer |
2016-02-29 |
| NCT02766634 |
A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen) |
https://ClinicalTrials.gov/show/NCT02766634 |
Completed |
Pfizer |
2016-06-30 |
| NCT02816164 |
A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia |
https://ClinicalTrials.gov/show/NCT02816164 |
Completed |
Ottawa Hospital Research Institute |
2019-02-28 |
| NCT04000711 |
Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia |
https://ClinicalTrials.gov/show/NCT04000711 |
Completed |
Hospital Infantil de Mexico Federico Gomez |
2017-09-30 |
| NCT00784368 |
A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection |
https://ClinicalTrials.gov/show/NCT00784368 |
Completed |
Janssen Pharmaceutical K.K. |
2009-04-30 |
| NCT00776165 |
Safety and Efficacy Trial of Recombinant Human Granulocyte Colony Stimulating Factor (GCSF) |
https://ClinicalTrials.gov/show/NCT00776165 |
Completed |
Shantha Biotechnics Limited |
2009-07-31 |
| NCT00771810 |
Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer |
https://ClinicalTrials.gov/show/NCT00771810 |
Completed |
Tarix Pharmaceuticals |
2011-12-31 |
| NCT00771433 |
G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer |
https://ClinicalTrials.gov/show/NCT00771433 |
Completed |
National Cancer Institute (NCI) |
2011-05-31 |
| NCT00770172 |
G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT00770172 |
Completed |
National Cancer Institute (NCI) |
2011-05-31 |
| NCT00730314 |
Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells |
https://ClinicalTrials.gov/show/NCT00730314 |
Completed |
Children’s Hospital Los Angeles |
2015-08-31 |
| NCT00709358 |
Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections |
https://ClinicalTrials.gov/show/NCT00709358 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2010-09-30 |
| NCT00686543 |
Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) |
https://ClinicalTrials.gov/show/NCT00686543 |
Completed |
Merck Sharp & Dohme Corp. |
2009-04-30 |
| NCT00627393 |
Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) |
https://ClinicalTrials.gov/show/NCT00627393 |
Completed |
HealthCore-NERI |
2013-04-30 |
| NCT00608738 |
Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment |
https://ClinicalTrials.gov/show/NCT00608738 |
Completed |
Northwestern University |
2005-01-31 |
| NCT00548080 |
Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055) |
https://ClinicalTrials.gov/show/NCT00548080 |
Completed |
Merck Sharp & Dohme Corp. |
2006-11-30 |
| NCT00541125 |
G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00541125 |
Completed |
Federation Francophone de Cancerologie Digestive |
2013-09-30 |
| NCT00536081 |
Various G-CSF Regimens to Prevent Infection During Chemotherapy |
https://ClinicalTrials.gov/show/NCT00536081 |
Completed |
Academisch Ziekenhuis Maastricht |
2009-12-31 |
| NCT00497809 |
Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia |
https://ClinicalTrials.gov/show/NCT00497809 |
Completed |
AviGenics |
2008-07-31 |
| NCT00454272 |
Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients |
https://ClinicalTrials.gov/show/NCT00454272 |
Completed |
Sanofi |
2007-08-31 |
| NCT00020371 |
BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy |
https://ClinicalTrials.gov/show/NCT00020371 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT01058993 |
AMD 3100 for Treatment of Myelokathexis |
https://ClinicalTrials.gov/show/NCT01058993 |
Completed |
University of Washington |
2011-03-31 |
| NCT00392951 |
Sirolimus for Autoimmune Disease of Blood Cells |
https://ClinicalTrials.gov/show/NCT00392951 |
Completed |
Children’s Hospital of Philadelphia |
2016-02-29 |
| NCT00379964 |
A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00379964 |
Completed |
Merck Sharp & Dohme Corp. |
2006-05-31 |
| NCT00364468 |
Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients |
https://ClinicalTrials.gov/show/NCT00364468 |
Completed |
Kyowa Kirin Co., Ltd. |
2008-03-31 |
| NCT00352300 |
Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer |
https://ClinicalTrials.gov/show/NCT00352300 |
Completed |
Gynecologic Oncology Group |
2010-07-31 |
| NCT00335478 |
Daptomycin in Treating Neutropenia and Fever in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00335478 |
Completed |
OHSU Knight Cancer Institute |
2008-10-31 |
| NCT00305708 |
Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission |
https://ClinicalTrials.gov/show/NCT00305708 |
Completed |
University of California, San Francisco |
2004-07-31 |
| NCT00301834 |
Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00301834 |
Completed |
University of California, San Francisco |
2011-09-30 |
| NCT00295971 |
Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease |
https://ClinicalTrials.gov/show/NCT00295971 |
Completed |
University of California, San Francisco |
2011-12-31 |
| NCT00292071 |
Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042) |
https://ClinicalTrials.gov/show/NCT00292071 |
Completed |
Merck Sharp & Dohme Corp. |
2006-07-31 |
| NCT00277160 |
A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer |
https://ClinicalTrials.gov/show/NCT00277160 |
Completed |
Amgen |
2004-11-30 |
| NCT00260689 |
Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00260689 |
Completed |
National Institutes of Health Clinical Center (CC) |
2016-05-04 |
| NCT00257790 |
The Tobramycin Study |
https://ClinicalTrials.gov/show/NCT00257790 |
Completed |
Oslo University Hospital |
NA |
| NCT00213759 |
Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF |
https://ClinicalTrials.gov/show/NCT00213759 |
Completed |
University Hospital, Strasbourg, France |
NA |
| NCT00176878 |
Stem Cell Transplant for Bone Marrow Failure Syndromes |
https://ClinicalTrials.gov/show/NCT00176878 |
Completed |
Masonic Cancer Center, University of Minnesota |
2009-03-31 |
| NCT00176852 |
Stem Cell Transplant for Hemoglobinopathy |
https://ClinicalTrials.gov/show/NCT00176852 |
Completed |
Masonic Cancer Center, University of Minnesota |
2014-03-31 |
| NCT00174473 |
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children |
https://ClinicalTrials.gov/show/NCT00174473 |
Completed |
Pfizer |
NA |
| NCT02324231 |
SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia |
https://ClinicalTrials.gov/show/NCT02324231 |
Completed |
Swiss Pediatric Oncology Group |
2018-09-15 |
| NCT00138736 |
Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia |
https://ClinicalTrials.gov/show/NCT00138736 |
Completed |
Sanquin Plasma Products BV |
NA |
| NCT00137787 |
Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases |
https://ClinicalTrials.gov/show/NCT00137787 |
Completed |
Center for Supporting Hematology-Oncology Trials |
2009-12-31 |
| NCT00129688 |
Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children |
https://ClinicalTrials.gov/show/NCT00129688 |
Completed |
Khon Kaen University |
NA |
| NCT00125723 |
FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy |
https://ClinicalTrials.gov/show/NCT00125723 |
Completed |
Amgen |
2005-12-31 |
| NCT00115414 |
Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) |
https://ClinicalTrials.gov/show/NCT00115414 |
Completed |
Amgen |
NA |
| NCT00004215 |
Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00004215 |
Completed |
Memorial Sloan Kettering Cancer Center |
2000-08-31 |
| NCT00002665 |
SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT00002665 |
Completed |
Southwest Oncology Group |
2001-12-31 |
| NCT00004192 |
Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00004192 |
Completed |
University of Nebraska |
2001-02-28 |
| NCT00082537 |
MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044) |
https://ClinicalTrials.gov/show/NCT00082537 |
Completed |
Merck Sharp & Dohme Corp. |
2006-10-31 |
| NCT00002719 |
Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00002719 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2001-11-30 |
| NCT00002866 |
Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer |
https://ClinicalTrials.gov/show/NCT00002866 |
Completed |
Canadian Cancer Trials Group |
2005-07-19 |
| NCT00002800 |
Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00002800 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-03-31 |
| NCT00002759 |
Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00002759 |
Completed |
National Cancer Institute (NCI) |
2002-04-30 |
| NCT00077311 |
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00077311 |
Completed |
Alliance for Clinical Trials in Oncology |
2006-07-31 |
| NCT00068471 |
Anidulafungin in Treating Immunocompromised Children With Neutropenia |
https://ClinicalTrials.gov/show/NCT00068471 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00008359 |
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment |
https://ClinicalTrials.gov/show/NCT00008359 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-03-31 |
| NCT00066599 |
Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy |
https://ClinicalTrials.gov/show/NCT00066599 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00002643 |
Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing’s Sarcoma or Primitive Neuroectodermal Tumor |
https://ClinicalTrials.gov/show/NCT00002643 |
Completed |
National Cancer Institute (NCI) |
2003-06-30 |
| NCT00002693 |
Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia |
https://ClinicalTrials.gov/show/NCT00002693 |
Completed |
Mayo Clinic |
2006-04-30 |
| NCT00031980 |
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00031980 |
Completed |
Alliance for Clinical Trials in Oncology |
2005-05-31 |
| NCT00020527 |
Caspofungin Acetate in Treating Children With Fever and Neutropenia |
https://ClinicalTrials.gov/show/NCT00020527 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00003739 |
Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy |
https://ClinicalTrials.gov/show/NCT00003739 |
Completed |
Children’s Oncology Group |
2002-12-31 |
| NCT00001790 |
Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia |
https://ClinicalTrials.gov/show/NCT00001790 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001646 |
Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis |
https://ClinicalTrials.gov/show/NCT00001646 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001533 |
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine |
https://ClinicalTrials.gov/show/NCT00001533 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001338 |
A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer |
https://ClinicalTrials.gov/show/NCT00001338 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00044486 |
Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899) |
https://ClinicalTrials.gov/show/NCT00044486 |
Completed |
Merck Sharp & Dohme Corp. |
2004-12-31 |
| NCT00035620 |
Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT00035620 |
Completed |
Amgen |
2007-01-31 |
| NCT00035594 |
Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT00035594 |
Completed |
Amgen |
2004-02-29 |
| NCT00056381 |
Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17 |
https://ClinicalTrials.gov/show/NCT00056381 |
Completed |
Pfizer |
NA |
| NCT00035425 |
Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection |
https://ClinicalTrials.gov/show/NCT00035425 |
Completed |
Pfizer |
NA |
| NCT00002263 |
A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine |
https://ClinicalTrials.gov/show/NCT00002263 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002126 |
A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection. |
https://ClinicalTrials.gov/show/NCT00002126 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00005893 |
Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00005893 |
Completed |
Office of Rare Diseases (ORD) |
NA |